Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01543581
Title Vismodegib for Treatment of Basal Cell Carcinoma (Erivedge)
Acronym Erivedge
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Abel Torres, MD
Indications
Therapies
Age Groups: senior | adult
Covered Countries

Facility Status City State Zip Country Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field